Resuscitation Ventilation with CCSV – Experience the Innovation at ERC Congress in Freiburg
(Hamburg) – Medical device manufacturer WEINMANN Emergency has developed a ventilation mode specially designed for resuscitation, Chest Compression Synchronized Ventilation (CCSV). CCSV applies a pressure-controlled mechanical breath synchronously with each chest compression, avoiding the disadvantages of conventional ventilation forms during resuscitation, while simultaneously improving gas exchange and hemodynamics. For the first time, mechanical breaths with a regulated peak pressure are delivered synchronously with chest compressions – a revolution that could replace volume-controlled ventilation as the gold standard for resuscitation! Be curious and learn more about CCSV at this yearÂ´s ERC Congress, 28th to 30th September, in Freiburg. With CCSV, WEINMANN Emergency introduces a ventilation mode for the emergency medical device MEDUMAT StandardÂ² that can be fully integrated into today's resuscitation process and is compatible with existing automatic chest compression devices. During chest compression, the heart and the pulmonary vessels in the lung are compressed, which also results in gas volume escaping from the lung below. Surrounded by soft tissue, the heart can thus compress only to a limited extent. The CCSV ventilation mode revolutionizes this decades-old procedure. CCSV modifies the principle of resuscitation as follows: The synchronized stroke causes the thoracic pressure to additionally increase during the compression phase. ...
In conclusion, 1) abnormal pattern of melatonin release in the late stages of HD and in moderate AIS occurs in conjunction with phase-advanced rhythm of cortisol; 2) changes observed in late stages of HD are similar to those that occur with ageing; 3) brain regions other than the presumptive retinopineal neural pathway may play an important role in the pineal production of melatonin in humans; 4) lesion in extrahypothalamic region is related to the strong adrenal stimulation in response to AIS. PMID: 29151070 [PubMed - in process]
To examine the relationship between functional gain and societal reintegration in patients receiving a home-based stroke outpatient rehabilitation program in Southwestern Ontario.
To compare functional outcomes of participants with traumatic brain injury (TBI) and stroke (CVA) who participated in a post-acute brain injury rehabilitation (PABIR) program, and to determine if admit total Disability Rating Scale (DRS) and Supervision Rating Scale (SRS) scores are predictive of discharge scores.
To evaluate the change in gait speed pre- and post-treatment. To evaluate the change in quality of life pre- and post-treatment. To evaluate the change in outcome measures pre- and post-treatment.
To examine feasibility of a cognitive training called Strategic Memory Advanced Reasoning Training (SMART) in adults with chronic stroke. The SMART program teaches strategies of strategic attention, integrated reasoning, and innovation to improve executive functions and performance in various aspects of daily-life.
To explore the influence of the home environment on Multiple Errands Test Home Version (MET-Home) performance among adults with stroke.
To obtain data from able-bodied participants to evaluate the performance and functionality of the new Tongue-Operated Exoskeleton system, which translate the tongue gestures to control commands initiated by the user to train the upper limbs. We have developed a novel robotic upper limbs rehabilitation system by combining a wireless and wearable assistive technology, called the Tongue Drive System (TDS) with an exoskeleton robot, called the KINARMTM (KA).
To determine fidelity of studies evaluating the efficacy of Neuro-Developmental Treatment (NDT) for upper extremity (UE) in acute stroke rehabilitation with 2016 NDT Association (NDTA) guidelines.
To examine the safety and efficacy of incobotulinumtoxinA for treating sialorrhea.
To investigate the causes of ischemic stroke in young, previously presumed healthy individuals. To investigate rehabilitation outcomes of ischemic stroke in young, previously presumed healthy individual. To review the presentation and treatment of disease in those with factor V Leiden and the role of the physiatrist. To evaluate clinical discussion about how this may affect family/offspring.